FirstHealth of the Carolinas

Clinical Trial Details

Study Title: GOG 225: Can Diet and Physical Activity Modulate Ovarian and Primary Peritoneal Cancer Progression-Free Survival?
Study Type: Interventional
Study Condition: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Investigator: Dr. John Byron
Phone: (910) 692-7928
Research Coordinator: Pam Mason
Phone: (910) 715-2200
Eligibility Criteria: Women, ages 18 years or older, with confirmed ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal carcinoma. For additional criteria, call the Research Coordinator or visit the study weblink.
Sponsor Organization: Gynecologic Oncology Group
Study Rationale: A healthy lifestyle and counseling (coaching) after treatment may improve progression-free survival in patients with previously treated cancer.
Study Purpose: This randomized phase III trial is studying diet and physical activity changes to see how well they work compared with usual care in improving progression-free survival of patients with previously treated stage II, stage III, or stage IV ovarian epithelial cancer, fallopian tube cancer, or primary peritoneal cancer.
Study Link: http://clinicaltrials.gov/show/NCT00719303
   
 
FirstHealth @ Facebook.comFirstHealth @ Twitter.comFirstHealth @ Pinterest.comFirstHealth @ LinkedIn.com
Physicians Employees
Working Together, First in Quality, First in Health
Site MapPrivacy PolicyTerms & ConditionsHelp © FirstHealth of the Carolinas, Inc.